Literature DB >> 19279139

Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.

Emmanuel Planel1, Alexis Bretteville, Li Liu, Laszlo Virag, Angela L Du, Wai Haung Yu, Dennis W Dickson, Robert A Whittington, Karen E Duff.   

Abstract

Alzheimer's disease and other tauopathies are characterized by the presence of intracellular neurofibrillary tangles composed of hyperphosphorylated, insoluble tau. General anesthesia has been shown to be associated with increased risk of Alzheimer's disease, and we have previously demonstrated that anesthesia induces hypothermia, which leads to overt tau hyperphosphorylation in the brain of mice regardless of the anesthetic used. To investigate whether anesthesia enhances the long-term risk of developing pathological forms of tau, we exposed a mouse model with tauopathy to anesthesia and monitored the outcome at two time points-during anesthesia, or 1 wk after exposure. We found that exposure to isoflurane at clinically relevant doses led to increased levels of phospho-tau, increased insoluble, aggregated forms of tau, and detachment of tau from microtubules. Furthermore, levels of phospho-tau distributed in the neuropil, as well as in cell bodies increased. Interestingly, the level of insoluble tau was increased 1 wk following anesthesia, suggesting that anesthesia precipitates changes in the brain that provoke the later development of tauopathy. Overall, our results suggest that anesthesia-induced hypothermia could lead to an acceleration of tau pathology in vivo that could have significant clinical implications for patients with early stage, or overt neurofibrillary tangle pathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279139      PMCID: PMC2717763          DOI: 10.1096/fj.08-122424

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  50 in total

1.  Alzheimer's disease and anaesthesia.

Authors:  I Bone; M Rosen
Journal:  Anaesthesia       Date:  2000-06       Impact factor: 6.955

2.  Body temperature as a risk factor for Alzheimer's disease.

Authors:  A Holtzman; E W Simon
Journal:  Med Hypotheses       Date:  2000-11       Impact factor: 1.538

3.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.

Authors:  J Lewis; E McGowan; J Rockwood; H Melrose; P Nacharaju; M Van Slegtenhorst; K Gwinn-Hardy; M Paul Murphy; M Baker; X Yu; K Duff; J Hardy; A Corral; W L Lin; S H Yen; D W Dickson; P Davies; M Hutton
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

Review 4.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

Review 5.  The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.

Authors:  R B Maccioni; C Otth; I I Concha; J P Muñoz
Journal:  Eur J Biochem       Date:  2001-03

6.  Protein phosphatase inhibitors induce the selective breakdown of stable microtubules in fibroblasts and epithelial cells.

Authors:  G Gurland; G G Gundersen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

Review 7.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.

Authors:  L Buée; T Bussière; V Buée-Scherrer; A Delacourte; P R Hof
Journal:  Brain Res Brain Res Rev       Date:  2000-08

8.  Conformational change as one of the earliest alterations of tau in Alzheimer's disease.

Authors:  C L Weaver; M Espinoza; Y Kress; P Davies
Journal:  Neurobiol Aging       Date:  2000 Sep-Oct       Impact factor: 4.673

9.  Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain.

Authors:  M Bennecib; C X Gong; I Grundke-Iqbal; K Iqbal
Journal:  FEBS Lett       Date:  2000-11-17       Impact factor: 4.124

Review 10.  Perioperative heat balance.

Authors:  D I Sessler
Journal:  Anesthesiology       Date:  2000-02       Impact factor: 7.892

View more
  58 in total

1.  Spine Surgery under general anesthesia may not increase the risk of Alzheimer's disease.

Authors:  Chaoshun Zuo; Zhiyi Zuo
Journal:  Dement Geriatr Cogn Disord       Date:  2010-04-06       Impact factor: 2.959

Review 2.  Brief review: anesthetic neurotoxicity in the elderly, cognitive dysfunction and Alzheimer's disease.

Authors:  Edward A Bittner; Yun Yue; Zhongcong Xie
Journal:  Can J Anaesth       Date:  2010-12-21       Impact factor: 5.063

3.  Administration of the benzodiazepine midazolam increases tau phosphorylation in the mouse brain.

Authors:  Robert A Whittington; László Virág; Maud Gratuze; Hilana Lewkowitz-Shpuntoff; Mehdi Cheheltanan; Franck Petry; Isabelle Poitras; Françoise Morin; Emmanuel Planel
Journal:  Neurobiol Aging       Date:  2018-11-08       Impact factor: 4.673

Review 4.  General Anesthetic Use in Fragile X Spectrum Disorders.

Authors:  Andrew Ligsay; Marwa El-Deeb; Maria J Salcedo-Arellano; Nina Schloemerkemper; Jeremy S Grayson; Randi Hagerman
Journal:  J Neurosurg Anesthesiol       Date:  2019-07       Impact factor: 3.956

Review 5.  Anesthetic modulation of neuroinflammation in Alzheimer's disease.

Authors:  Junxia X Tang; Maryellen F Eckenhoff; Roderic G Eckenhoff
Journal:  Curr Opin Anaesthesiol       Date:  2011-08       Impact factor: 2.706

6.  The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells.

Authors:  Cesar Augusto Dias de Paula; Fernando Enrique Santiago; Adriele Silva Alves de Oliveira; Fernando Augusto Oliveira; Maria Camila Almeida; Daniel Carneiro Carrettiero
Journal:  Cell Mol Neurobiol       Date:  2015-07-25       Impact factor: 5.046

Review 7.  Lasting impact of general anaesthesia on the brain: mechanisms and relevance.

Authors:  Laszlo Vutskits; Zhongcong Xie
Journal:  Nat Rev Neurosci       Date:  2016-10-18       Impact factor: 34.870

Review 8.  Anesthesia and tau pathology.

Authors:  Robert A Whittington; Alexis Bretteville; Maya F Dickler; Emmanuel Planel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-03-25       Impact factor: 5.067

9.  Hippocampal glutamate level and glutamate aspartate transporter (GLAST) are up-regulated in senior rat associated with isoflurane-induced spatial learning/memory impairment.

Authors:  Xiangdong Qu; Chengshi Xu; Hui Wang; Jie Xu; Weiran Liu; Yun Wang; Xingyuan Jia; Zhongcong Xie; Zhipeng Xu; Chao Ji; Anshi Wu; Yun Yue
Journal:  Neurochem Res       Date:  2012-10-16       Impact factor: 3.996

10.  Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  Yazi D Ke; Fabien Delerue; Amadeus Gladbach; Jürgen Götz; Lars M Ittner
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.